Onconova Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. In this edition of Deal Watch, we highl

Morningside Ventures launched Adiso Therapeutics on 10 March with more than $60m invested to date in the Concord, MA-based start-up focusing on the underlying biology of inflammatory diseases without

Onconova Therapeutics, Inc. . is looking at an uncertain future following the failure of its lead product, intravenous rigosertib, in the Phase III INSPIRE trial in myelodysplastic syndromes. The stud

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . US, Chinese Vaccine Develope